Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Active, not recruiting Not applicable

Effect of Perception-based Interventions on Public Acceptance of Using Large Language Models in Medicine

NCT07304908 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2025-11-25
Last updated
2025-12-26

Condition(s) studied

Large Language ModelsAcceptability of Health CarePerception, Self

Investigational drug(s) / intervention(s)

Perception-based interventions

Perception-based interventions: Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.

Study summary

Large language models (LLMs) show promise in medicine, but concerns about their accuracy, coherence, transparency, and ethics remain. To date, public perceptions on using LLMs in medicine and whether they play a role in the acceptability of health care applications of LLMs are not yet fully understood. This study aims to investigate public perceptions on using LLMs in medicine and if interventions for perceptions affect the acceptability of health care applications of LLMs.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * ≥18 years * Capable of completing an online survey * Agree to sign an informed consent form Exclusion Criteria: * Unable to answer questions or communicate * Not willing to participate in this study

Primary outcome measure(s)

  • Number of participants who will change their attitudes towards medical applications of large language models — Through study completion, an average of 1 year
    Public acceptance of applying large language models to medicine will be categorized into yes, not sure, and no, which will be collected before perception-based interventions and after interventions.

Trial sites (1)

FacilityCityRegionStatus
Jue Liu Beijing Beijing Municipality
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07304908 on ClinicalTrials.gov ↗ ← All trials in China